Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide-brimonidine for IOP after phacoemulsification
NCT03494257Completed
- Sponsor
- University General Hospital of Patras
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brinzolamide + brimonidine in ocular hypertension (2 arms), sponsored by University General Hospital of Patras. Primary endpoint: Intraocular Pressure at 6 hours. Started Sep 2017; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT03494257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494257.